Publications To Date


    Filter Publications

    PAGE 7 OF 146 | DISPLAYING 91 - 105 OF 2181 RESULTS

    De. Jager P.L. et. al., A multi-omic atlas of the human frontal cortex for aging and Alzheimer’s disease research,, Scientific Data, Aug 07, 2018

    Dahl M. et. al., Enzyme-free digital counting of endogenous circular RNA molecules in B-cell malignancies,, Lab. Invest., Aug 07, 2018

    Ehrlich A.T. et. al., Expression map of 78 brain-expressed mouse orphan GPCRs provides a translational resource for neuropsychiatric research,, Communications Biology, Aug 06, 2018

    Chan J.P. et. al., The lysolipid transporter Mfsd2a regulates lipogenesis in the developing brain, 10.1371/journal.pbio.2006443, PLoS bIOL., Aug 03, 2018

    Silva J.P. et. al., Analysis of diet-induced differential methylation, expression, and interactions of lncRNA and protein-coding genes in mouse liver,, Sci. Reports, Aug 01, 2018

    Kim S-S. et. al., Combination with SGT-53 overcomes tumor resistance to a checkpoint inhibitor, 10.1080/2162402X.2018.1484982, Oncoimmunology, Aug 01, 2018

    Li Y. et. al., A human immune system mouse model with robust lymph node development,, Nature Med., Jul 31, 2018

    Polumuri S.K. et. al., Aggregates of IVIG or Avastin, but not HSA, modify the response to model innate immune response modulating impurities,, Sci. Reports, Jul 31, 2018

    Alidousty C. et. al., Genetic instability and recurrent MYC amplification in ALK‐translocated NSCLC: a central role of TP53 mutations, 10.1002/path.5110, J. Pathol., Jul 31, 2018

    Kim Y-S. et. al., Fibroblast growth factor receptor 3 (FGFR3) aberrations in muscle-invasive urothelial carcinoma, 10.1186/s12894-018-0380-1, BMC. Urol., Jul 31, 2018

    de Vos S. et. al., Venetoclax, bendamustine, and rituximab in patients with relapsed or refractory NHL: a phase Ib dose-finding study, 10.1093/annonc/mdy256, Ann. Oncol., Jul 28, 2018

    Liu H. et. al., Functional convergence of gliP and aspf1 in Aspergillus fumigatus pathogenicity, 10.1080/21505594.2018.1482182, Virulence, Jul 27, 2018

    Jensen M-B. et. al., The Prosigna gene expression assay and responsiveness to adjuvant cyclophosphamide-based chemotherapy in premenopausal high-risk patients with breast cancer, 10.1186/s13058-018-1012-0, Breast Can. Res., Jul 27, 2018

    Oliviera J.J. et. al., The plasma biomarker soluble SIGLEC-1 is associated with the type I interferon transcriptional signature, ethnic background and renal disease in systemic lupus erythematosus, 10.1186/s13075-018-1649-1, Arthritis Res. Ther., Jul 27, 2018

    Ghaffari A. et. al., STING agonist therapy in combination with PD-1 immune checkpoint blockade enhances response to carboplatin chemotherapy in high-grade serous ovarian cancer,, Br. J. Cancer, Jul 26, 2018